Lab-grown chocolate is moving closer to commercial reality, with global confectionery giant Mondelez International advancing plans to bring products made with cell-cultured cocoa ingredients to market by 2027 as the industry grapples with soaring cocoa prices, climate-related supply disruptions and growing sustainability pressures.
The company, which owns globally recognised brands including Oreo, Cadbury and Toblerone, has emerged as one of the most prominent corporate backers of cellular agriculture in the cocoa sector through its partnership with Israeli biotechnology firm Celleste Bio. The collaboration is focused on producing cocoa ingredients in controlled bioreactor facilities rather than relying entirely on traditional farming.
A major milestone was achieved in April 2026 when Mondelez successfully manufactured what has been described as the world’s first milk chocolate bars made with cell-cultured cocoa butter. The prototype products reportedly met internal standards for taste, texture and overall product performance, demonstrating that laboratory-produced cocoa butter can function in commercial chocolate production.
According to Brandspur Brand News, the breakthrough comes at a time when chocolate manufacturers worldwide are facing one of the most severe cocoa supply challenges in decades. Adverse weather conditions, crop diseases and ageing plantations across major cocoa-producing countries have significantly reduced output and contributed to unprecedented volatility in global cocoa markets.
Celleste Bio’s technology begins with cells extracted from a cocoa bean. These cells are cultivated in nutrient-rich bioreactors where they multiply and produce cocoa components that can later be processed into cocoa butter. The company says a single cocoa bean can ultimately support production volumes that would traditionally require substantial farmland, highlighting the technology’s potential efficiency gains.
Industry interest in alternative cocoa production has intensified following a sharp rise in cocoa prices over the past two years. Global chocolate manufacturers have faced mounting pressure from reduced harvests in West Africa, the region responsible for the majority of the world’s cocoa supply. Climate variability, prolonged heat waves, excessive rainfall and plant diseases have all affected yields, raising concerns about the long-term stability of conventional cocoa farming.
Supporters of cultivated cocoa argue that the technology could help stabilise supply chains, reduce dependence on unpredictable harvest cycles and lower exposure to environmental risks. They also point to potential benefits in reducing deforestation pressures associated with agricultural expansion and improving traceability within global cocoa supply networks.
The commercialisation process, however, remains subject to regulatory approval. Celleste Bio is reportedly preparing submissions for food safety reviews in key markets including the United States, the United Kingdom, Israel and the European Union before products can be widely sold to consumers.
Consumer acceptance is expected to become one of the industry’s biggest tests. While developers maintain that cell-cultured cocoa butter is chemically equivalent to conventionally produced cocoa butter and delivers the same sensory characteristics, some consumers remain cautious about laboratory-produced food ingredients and their role in mainstream food production.
The emergence of cultivated cocoa also raises broader questions for major cocoa-producing nations, including those in West Africa, whose economies and farming communities depend heavily on cocoa exports. Industry observers note that large-scale adoption of alternative cocoa technologies could eventually reshape global supply chains, although traditional cocoa farming is expected to remain a significant source of supply for the foreseeable future.
Beyond cultivated cocoa, several food technology companies are also developing cocoa-free chocolate alternatives using ingredients such as fermented grains, sunflower seeds and other plant-based raw materials. However, cultivated cocoa differs from these approaches because it is designed to produce genuine cocoa-derived ingredients rather than substitutes intended to mimic chocolate flavour.
With pilot-scale facilities now under development and commercial production targets set for 2027, the chocolate industry appears to be entering a new phase where biotechnology could play a growing role alongside traditional agriculture. Whether consumers embrace the innovation remains uncertain, but the race to secure future cocoa supplies is increasingly pushing major manufacturers toward scientific alternatives once considered experimental.
